• / Free eNewsletters & Magazine
  • / My Account
Home>Newly Appointed Acting CEO Outlines Immediate Plans for Novogen

Newly Appointed Acting CEO Outlines Immediate Plans for Novogen

3party Content

Thu, 30 Jul 2015

Company Confirms Its Commitment to Bringing Technology Platforms to the ClinicSYDNEY, July 29, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Limited (ASX: NRT; NASDAQ: NVGN) today confirmed it is committed to progressing its ground-breaking technology platforms to Phase 1
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.